Factors controlling the pharmacokinetics, biodistribution and intratumoral penetration of nanoparticles.
about
Lipid nanoparticles for targeted siRNA delivery - going from bench to bedsideRecent insights in nanotechnology-based drugs and formulations designed for effective anti-cancer therapyCritical questions in development of targeted nanoparticle therapeuticsNanoparticles for Cardiovascular Imaging and Therapeutic Delivery, Part 1: Compositions and FeaturesActive Tumor Permeation and Uptake of Surface Charge-Switchable Theranostic Nanoparticles for Imaging-Guided Photothermal/Chemo Combinatorial Therapy.A Cholecystokinin B Receptor-Specific DNA Aptamer for Targeting Pancreatic Ductal AdenocarcinomaRadioactive 198Au-doped nanostructures with different shapes for in vivo analyses of their biodistribution, tumor uptake, and intratumoral distribution.Subtumoral analysis of PRINT nanoparticle distribution reveals targeting variation based on cellular and particle propertiesDesign of acid-responsive polymeric nanoparticles for 7,3',4'-trihydroxyisoflavone topical administrationEfficient co-delivery of immiscible hydrophilic/hydrophobic chemotherapeutics by lipid emulsions for improved treatment of cancer.Intelligent recognitive systems in nanomedicine.Smart pH-sensitive nanoassemblies with cleavable PEGylation for tumor targeted drug delivery.Hyaluronan polymer length, grafting density, and surface poly(ethylene glycol) coating influence in vivo circulation and tumor targeting of hyaluronan-grafted liposomes.Emerging Role of the Spleen in the Pharmacokinetics of Monoclonal Antibodies, Nanoparticles and Exosomes.Inhalable PEGylated Phospholipid Nanocarriers and PEGylated Therapeutics for Respiratory Delivery as Aerosolized Colloidal Dispersions and Dry Powder Inhalers.Improving the distribution of Doxil® in the tumor matrix by depletion of tumor hyaluronanEnhancing radiotherapy by lipid nanocapsule-mediated delivery of amphiphilic gold nanoparticles to intracellular membranesInfluence of polyethylene glycol coating on biodistribution and toxicity of nanoscale graphene oxide in mice after intravenous injection.Targeted photodynamic therapy in head and neck squamous cell carcinoma: heading into the future.CD47 Enhances In Vivo Functionality of Artificial Antigen-Presenting CellsDelivery of size-controlled long-circulating polymersomes in solid tumours, visualized by quantum dots and optical imaging in vivo.Cooperative Treatment of Metastatic Breast Cancer Using Host-Guest Nanoplatform Coloaded with Docetaxel and siRNA.Multifunctional organically modified silica nanoparticles for chemotherapy, adjuvant hyperthermia and near infrared imagingSodium-22-radiolabeled silica nanoparticles as new radiotracer for biomedical applications: in vivo positron emission tomography imaging, biodistribution, and biocompatibilityGlutathione-degradable drug-loaded nanogel effectively and securely suppresses hepatoma in mouse model.Strategies to Improve Cancer Photothermal Therapy Mediated by Nanomaterials.Folic acid-functionalized drug delivery platform of resveratrol based on Pluronic 127/D-α-tocopheryl polyethylene glycol 1000 succinate mixed micellesTriple-Layered pH-Responsive Micelleplexes Loaded with siRNA and Cisplatin Prodrug for NF-Kappa B Targeted Treatment of Metastatic Breast Cancer.Drug delivery systems for ovarian cancer treatment: a systematic review and meta-analysis of animal studies.Effect of surface properties on liposomal siRNA delivery.A prodrug-doped cellular Trojan Horse for the potential treatment of prostate cancer.Image-guided tumor surgery: will there be a role for fluorescent nanoparticles?Charge effect of a liposomal delivery system encapsulating simvastatin to treat experimental ischemic stroke in ratsPolymeric nanocapsules with up-converting nanocrystals cargo make ideal fluorescent bioprobes.Gold Nanoparticle-Mediated Targeted Delivery of Recombinant Human Endostatin Normalizes Tumour Vasculature and Improves Cancer Therapy.Influence of Molecular Structure on the In Vivo Performance of Flexible Rod Polyrotaxanes.Drug-loadable Mesoporous Bioactive Glass Nanospheres: Biodistribution, Clearance, BRL Cellular Location and Systemic Risk Assessment via (45)Ca Labelling and Histological AnalysisSize effect of Au/PAMAM contrast agent on CT imaging of reticuloendothelial system and tumor tissue.Probing nanoparticle translocation across the permeable endothelium in experimental atherosclerosis.Docetaxel-loaded PLGA and PLGA-PEG nanoparticles for intravenous application: pharmacokinetics and biodistribution profile.
P2860
Q26741449-15168A10-1AA7-4170-A57B-2D7086B96E80Q26745710-156513E5-FF56-44A9-AF2B-57E3F330A21EQ26751896-F4DDC024-ABB6-4DC6-A98B-0B2B0F139329Q26798426-00C25476-2ADB-4007-9CBB-146A6F63ADC6Q27300862-8DA001E8-340B-4E26-8911-98DD0B47DB52Q30275702-C35B9058-F8B1-43AE-B8DD-D05BACE545A0Q30413615-636576C7-026E-49E8-9D87-1B7C56A3DDD8Q30744724-17DA4CF0-8314-49F6-A512-563115A315BFQ31090201-8C88ABDF-AA3D-485F-8195-E84EB9E6861EQ33563252-8A930A9A-08A4-4521-A16A-F64C86B3A8BDQ33632768-E6584062-DB12-4826-A1EA-3C90DD25AF60Q33794267-F3A9C121-D9CD-4597-8092-6D7CA1F6DBFCQ33811463-AC2833AC-61D0-4E67-BBDD-0E967BB80AD3Q33838871-A7DC913E-1947-4CCA-8AC4-9A8F61AE6AE6Q33858681-B4DFD6A1-154A-48B8-94A2-C338062B2819Q34145464-E9332E6D-660D-4FE4-AA3A-DCBA8A15DFEAQ34324348-17A839B9-E6BA-4886-B298-C14760FA4F8FQ34391639-4EAC3FE7-544B-4F24-B109-2FCC2CFF0C45Q35538953-E4E0232E-45E4-46F4-B434-45AF17CD1053Q35563107-67789D5D-018E-4739-B787-A91117542D9EQ35613961-4F6F8523-B0C7-4F12-ABF3-236D8C973991Q35867861-9ED9DDBB-9986-472C-B11C-247AFC1EDB7BQ36129284-BCF14239-4485-41E8-93CF-E6FDF368E650Q36160430-126B11DD-2BB9-47C5-B5DA-96B7A518F28EQ36212932-B4DB420B-EB60-472F-B9DD-561F3BEA358DQ36316020-F17E2F10-A470-4F4F-99E2-7D01A8C9A93DQ36341468-E0050D84-3E1B-4C5B-BA44-B86EF90698B5Q36372323-D647C7E2-0793-4394-86F9-64D766E91820Q36402123-66D70FA2-BB37-4F0B-AD85-70A4CE525C86Q36421379-EE7CA63B-7536-4DDC-BFE1-EF365BE9FEE4Q36776738-FCC22E53-CF1E-4EB8-87C4-4D4161A34C3BQ36994932-F0D48C6A-1548-416A-9BB8-E059721BB965Q37070584-C36ECAD7-C772-4E45-809E-3F53821078DDQ37089691-82D3A29F-1FEC-48FB-B817-A997426B1701Q37137190-BFBCAA7D-F764-4C68-AF57-855A28AFEF53Q37254486-8F4AFFD8-E432-4E6E-B7D5-C45C88CE7BCFQ37257634-8421F2CC-50A6-4642-AB37-15508FCA3DCDQ37284538-47330702-697A-40CC-B4D7-64240537BE20Q37519622-A2F0DAFA-9EDD-4E60-A615-87506DFE2960Q37623841-38A69B3B-8AFB-4A8E-A6D7-E4E2B2223693
P2860
Factors controlling the pharmacokinetics, biodistribution and intratumoral penetration of nanoparticles.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 25 September 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Factors controlling the pharma ...... penetration of nanoparticles.
@en
Factors controlling the pharma ...... penetration of nanoparticles.
@nl
type
label
Factors controlling the pharma ...... penetration of nanoparticles.
@en
Factors controlling the pharma ...... penetration of nanoparticles.
@nl
prefLabel
Factors controlling the pharma ...... penetration of nanoparticles.
@en
Factors controlling the pharma ...... penetration of nanoparticles.
@nl
P2093
P2860
P1476
Factors controlling the pharma ...... penetration of nanoparticles.
@en
P2093
Mami Murakami
Mark J Ernsting
Shyh-Dar Li
P2860
P304
P356
10.1016/J.JCONREL.2013.09.013
P407
P577
2013-09-25T00:00:00Z